NICE has rejected regular NHS funding for Janssen ... other factors. Spravato is approved as an adjunctive therapy administered by a nasal spray and is based on esketamine, a form of the drug ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...